15 Jun Post-marketing Reporting Of Adverse Drug Reactions To Human Medicines In South Africa
Posted at 18:24h
in
This document serves as a guideline to those reporting adverse drug reactions. It represents the South African Health Products Regulatory Authority’s current thinking on the safety, quality and efficacy of medicines. The Authority reserves the right to request any additional information to establish the safety, quality and efficacy of a medicine and may make amendments to the approved conditions of registration in keeping with the knowledge which is current at the time of consideration of safety data.
Download latest version
Download archived version
Download archived version
Document Number:
SAHPGL-CEM-PV-04
Version:
9
Date Updated:
08/06/2022
File Type:
pdf
Category:
Guideline